Tumor development
Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL
11
Macrophages of distinct origins contribute to tumor development in the lung
56
ADAMTS-1 metalloproteinase induces a stromal reaction and propotes tumor development in mice.
15
The Prosurvival IKK-Related Kinase IKK« Integrates LPS and IL17A Signaling Cascades to Promote Wnt-Dependent Tumor Development in the Intestine
13
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rate
25
Tumor hypoxia modulates podoplanin/CCL21 interactions in CCR7+ NK cell recruitment and CCR7+ tumor cell mobilization
13
New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors
21
Capturing the Driving Role of Tumor-Host Crosstalk in a Dynamical Model of Tumor Growth
7
Ontogeny of Tumor-Associated Macrophages
8
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
35
Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
35
New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors
20
Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays
12
The role of ERα36 in development and tumor malignancy
24
Tumor Stiffening, a Key Determinant of Tumor Progression, is Reversed by Nanomaterial-Induced Photothermal Therapy.
16
Acoustic separation of circulating tumor cells
7
Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anti-cancer therapies
1
A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy
18
Design Considerations for Tumor-Targeted Nanoparticles
14
Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
16